Lomitapide, a Microsomal Triglyceride Transfer Protein Inhibitor, in Homozygous Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Cardiovasc Drugs Ther · 2026 · PMC13171640 · PMID 40856940

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

VLDL-C showed a decreasing trend with a mean change from baseline of −8.85 mg/dl (95% CI: [−10.92 to −6.78] as represented in Fig. 4 D), and a percentage reduction of −48.73 (95% CI: [−63.33 to −34.12] as represented in Fig. 5 D).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.